Clasp Therapeutics

About:

Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system.

Website: https://www.clasptx.com/home#about-us

Top Investors: Blackbird Ventures, Alexandria Venture Investments, Catalio Capital Management, Third Rock Ventures, Vivo Capital

Description:

Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system to identify and specifically destroy hard-to-treat tumors bearing common driver mutations, regardless of tumor type.

Total Funding Amount:

$150M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)clasptx.com

Founders:

Bert Vogelstein, Drew Mark Pardoll, Kellie N Smith, Kenneth Kinzler, Nickolas Papadopoulos, Shibin Zhou

Number of Employees:

11-50

Last Funding Date:

2024-03-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai